Gates Package — page 604

or In that you comment 1) the state of 2d discussion. 2eping flexible ' this format Eric (NIH/NHGRI) [E] Cc: Cantrel, Katherine (NIH/NIAID) [C]; Conrad, Patricia (NIH/NIAID) [E]; Stover, Kathleen (NIH/FIC) [E]; Qiao, Mo (NIH/NIDCR) [C]; Brown, Crystal (NIH/NICHD) [C]; Wilkerson, Anita D. (NIH/NIDDK) [E]; Poole, Charlene (NIH/NIDDK) [E]; Brawley, David (NIH/NIDDK) [E]; Izzard, Tom (NIH/NIBIB) [C]; Finnegan, Sean (NIH/NCATS) [C]; Wiszneauckas, Joy (NIH/NCI) [E]; Togashi, Mieko (NIH/NCI) [E]; Wells, Connie (NIH/NHLBI) [E]; Earle, Melody (NIH/NHLBI) [E]; Sante, Annette (NIH/NHGRI) [C]; Rodela, Gloria (NIH/VRC) [E]; Suhana, Tina (NIH/VRC) [E]; Lebron, Janette (NIH/NIAID) [C]; McManus, Ayanna (NIH/OD) [E]; Eiss, Robert (NIH/FIC) [E]; Burklow, John (NIH/OD) [E] Subject: Agenda for Bill Gates visit to NIH on December 2 Dear Colleagues, I am delighted you are able to join the roundtable discussion and working lunch with Bill Gates on Monday, December 2, from 12:15 AM-1:30 PM, to take place in the Medical Board Room of the NIH Clinical Center. Attached is the program for the visit, outlining the agenda for the roundtable discussion. The topics are based on conversations with Bill and other staff from the Global Health Program at the BMGF. Based on Bill's preferences, we are organizing the roundtable as a conversation, rather than a series of presentations. In order to make best use of available time, I have identified lead discussants for each agenda topic. I ask that you comment briefly, not to exceed 3 minutes, on one or several select scientific challenges of relevance to the BMGF: 1) the state of current knowledge and 2) the important questions to resolve. The comments would be intended to seed discussion. Unless you have compelling reasons to include powerpoints, I would suggest avoiding those for this informal conversation. I will try to ensure we cover as much of the agenda as feasible in the time available, while keeping flexible and responsive to Bill's interests and the flow of discussion. Could I ask lead discussants to confer with colleagues identified under their area, to discuss how to share the time allocated to introduce topics? Given Bill's extensive knowledge in global health R&D and scientific savvy, this format should work well and allow us to discuss the diverse scope of exciting science surrounding global health. Bill will be joined at the roundtable by Chris Wilson, Director of the Global Health Discovery & Translational Sciences program (and a member of the ACD); Trevor Mundel, President of the Global Health Program at the BMGF; Boris Nikolic, Scientific Advisor; and Kathy Young, Senior Project Manager for Strategic Planning and Engagement. Their bios are attached. Please feel free to contact Rob Eiss at FIC with any questions you or your staff may have surrounding the visit. I'm delighted that Bill was able to reschedule so soon after the shutdown, and will remain on campus a good portion of the day to visit labs and hold discussions with senior leadership, in addition to the presenting the annual David Barmes Global Health lecture. Best regards, Francis